Harvard has partnered Deerfield to launch commercialisation firm Lab1636 with $100m in funding in order to advance life science projects towards the clinic and establish spinouts.

Harvard University today announced a partnership with investment firm Deerfield Management to launch a $100m research and development initiative that will focus on the development and translation of biomedical and life science research. Lab1636 is a wholly-owned company of Deerfield affiliates and received the capital from the investment firm. It will focus on novel therapeutics…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.